pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
TAIHO ONCOLOGY · news · pharmadog
← back to TAIHO ONCOLOGY
News mentioning TAIHO ONCOLOGY
8
stories
3d
BioSpace 2027 Best Places to Work shines light on most admired employers
biospace
Oct 6, 26
ArriVent collapses on disappointing lung cancer data
biopharma dive
Sep 15, 26
Despite 3 patient deaths, Cullinan-Taiho plan FDA filing for lung cancer pill on survival benefit
biospace
Sep 11, 26
Cullinan, Taiho showcase 6-month survival benefit in phase 3 trial for advanced lung cancer
fiercebiotech
Aug 13, 26
New Taiho, Cullinan data heats up lung cancer drug battle
biopharma dive
Aug 13, 26
Taiho and Cullinan’s zipalertinib clears Phase 3, teeing up first-line competition
biospace
Aug 13, 26
Taiho, Cullinan's lung cancer drug passes Phase 3 test, lining up Rybrevant contest
endpoints
May 13, 26
FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AML
onclive
